# Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage

> **NCT02788617** · — · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 100 (actual)

## Conditions studied

- Infertility

## Interventions

- **DEVICE:** Diafert

## Key facts

- **NCT ID:** NCT02788617
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-24
- **Primary completion:** 2017-01-30
- **Final completion:** 2017-04-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788617, "Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02788617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*